Table 4.
Punica granatum Formulation | Effect | Model | Material | Dosage/Concentration | Mechanism | Study |
---|---|---|---|---|---|---|
Peel extract | Antifungal activity | Induced oral candidiasis | Wistar rats | 125 µg/mL, 250 µg/mL, 500 µg/mL | Inhibition of C. albicans growth |
Bassiri- Jahrom et al. [24] |
Peel and seed extract | Antibacterial activity | Measuring of MIC and MBC, time-dependent growth inhibition assay | MRSA strains | 1.25 mmol/L | Delay of initial growth of MRSA | Hussein et al. [25] |
Peel extract | Antibacterial and antifungal activity | Diffusion disc method, broth microdilution method | Various types of pathogens | 2.7 mg/mL | Inhibition of growth of different Gram-negative and Gram-positive bacteria and fungal pathogens | Kupnik et al. [26] |
Methanolic flower extract | Antifungal activity in treating chronic dandruff | Clinical trial | Human subjects | 28.1% (w/w) | Antioxidant activity, anti-itching and anti-inflammatory (inhibition of COX, LOX and PLA2) | Sahraie-Rad et al. [27] |